| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.2 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.2 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | NU-7441 | GDSC1000 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.2 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | -0.064 | 0.2 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.2 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.039 | 0.2 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.2 |